अब आप न्यूज्ड हिंदी में पढ़ सकते हैं। यहाँ क्लिक करें
cyfy
Home » business » Biocon net plunges 39% in Q2 to Rs 216 crore

Biocon net plunges 39% in Q2 to Rs 216 crore

The city-based company, however, said the net profit a year ago included Rs 171 crore exceptional income.

By IANS
Updated on :
Biocon net plunges 39% in Q2 to Rs 216 crore
Image: DNA

Bengaluru: Biotech major Biocon on Wednesday reported a Rs 216 crore consolidated net profit for the second quarter (Q2) of fiscal 2019-20, registering a 39 per cent decline from Rs 355 crore in the same period a year ago.

The city-based company, however, said the net profit a year ago included Rs 171 crore exceptional income.

Sequentially, net profit rose 5 per cent to Rs 216 crore from Rs 206 crore a quarter ago.

In a regulatory filing on the BSE, the city-based pharma company said consolidated revenue from sales grew 19 per cent annually to Rs 1,572 crore from Rs 1,322 crore in the like period a year ago.

Sequentially, revenue rose 7 per cent to Rs 1,572 crore from Rs 1,466 crore a quarter ago.

Earnings before interest, depreciation and amortisation (Ebitda) increased 12 per cent annually to Rs 441 crore from Rs 394 crore year ago but declined 4 per cent sequentially from Rs 462 crore a quarter ago.

–IANS

(This story has not been edited by Newsd staff and is auto-generated from a syndicated feed.)
(For more latest news and updates Like us on Facebook, Follow us on Twitter. Download our mobile app )

Related

Latests Posts


Editor's Choice


Trending